Geninus

Geninus Equity

The The Equity of Geninus (389030.KQ) as of Oct 17, 2026 is 9.10 B KRW. In the previous year, The Equity was 22.24 B KRW — a change of -59.07% (lower).

Equity

9.10 BKRW

YoY

-59.07%

Last updated:

In 2025, Geninus's equity was 9.10 B KRW, a -59.07% increase from the 22.24 B KRW equity in the previous year.

The Geninus Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
852.61 M KRW
Jan 1, 2019
-2.22 B KRW
Jan 1, 2020
-11.22 B KRW
Jan 1, 2021
51.91 B KRW
Jan 1, 2022
43.27 B KRW
Jan 1, 2023
34.49 B KRW
Jan 1, 2024
22.24 B KRW
Jan 1, 2025
9.10 B KRW
The Geninus Equity history
YEAREquityYoY
9.10 BKRW-59.07%
22.24 BKRW-35.52%
34.49 BKRW-20.30%
43.27 BKRW-16.64%
51.91 BKRW-562.46%
-11.22 BKRW+405.47%
-2.22 BKRW-360.44%
852.61 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Geninus Stock analysis

What does Geninus do? Geninus Inc is a South Korean company based in Seoul, operating in the Health Care sector within the Biotechnology industry. The company focuses on research and development of NGS-based genome analysis technology and develops genome analysis solutions. It provides single cell analysis services, genetic testing for disease prediction, cancer genome analysis based on tissue biopsy, and personal genetic testing. Geninus Inc has 94 employees and completed its IPO on November 8, 2021. Its website is http://www.kr-geninus.com/. Geninus is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Geninus's Equity

Geninus's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Geninus's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Geninus's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Geninus's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Geninus’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Geninus stock

The Equity of Geninus is 9.10 B KRW in 2025.

The Equity of Geninus changed from 22.24 B KRW to 9.10 B KRW, representing a -59.07% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Geninus since 2006 – with annual values, charts, and detailed analysis.

The Equity's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Geninus historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Geninus

All Key Metrics — Geninus